Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997709 · ClinicalTrials.gov registry record
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
A clinical trial of Prostate Cancer, sponsored by University of Miami.
- Recruiting
- Registry status
- 144
- Enrollment target
- 1
- Study location
NCT02997709 is a study of Prostate Cancer that is actively recruiting participants, run by University of Miami. The registered enrollment target is 144 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02997709, a study of Prostate Cancer, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn about: 1) How standard radiation treatment to prostate (primary radiotherapy) or the pelvis after prostatectomy (postoperative radiotherapy) may cause changes in MRI and PET imaging traits that might be used in the future to predict response. 2) Comparison of such MRI and PET imaging traits with the number of circulating tumor cells (CTCs) present in the blood prior to treatment and the changes in these counts after treatment. 3) How MRI and PET imaging characteristics and changes are related to the expression of genes in the cancer tissue obtained before treatment from prostate biopsy or a prior prostatectomy before treatment. 4) How the response of prostate cancer treatment relates to the imaging and CTC changes.
Conditions Studied
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2016-06-24 |
| Est. Completion | 2032-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02997709
The ClinicalTrials.gov registry entry for NCT02997709 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (76% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02997709 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02997709 about?
NCT02997709 is a clinical study titled "Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients". The purpose of this research study is to learn about: 1) How standard radiation treatment to prostate (primary radiotherapy) or the pelvis after prostatectomy (postoperative radiotherapy) may cause changes in MRI and PET imaging traits that might be used in the future to predict response. 2) Compari...
What is the current status of trial NCT02997709?
This trial is currently recruiting. The enrollment target is 144 participants. The study started on 2016-06-24. Estimated completion is 2032-06-30.
What conditions does trial NCT02997709 study?
This clinical trial studies the following conditions: Prostate Cancer.
Who is sponsoring clinical trial NCT02997709?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02997709 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.